Recurrent Laryngeal Nerve PalsyNCT04986592
Predisection Risk Factors for Vocal Cord Palsy After Total Thyroid Surgery
An observational study of Recurrent Laryngeal Nerve Palsy and Risk Factors of Vocal Cord Palsy, run by Hospital Universitari Vall d'Hebron Research Institute.
Trial summary
In patients undergoing total thyroidectomy, intraoperative nerve monitoring according to the International Standards Guideline Statement may detect nerves more susceptible to injury. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Recurrent Laryngeal Nerve Palsy, Risk Factors of Vocal Cord Palsy, Neuromonitoring in Thyroid Surgery
- How many people
- 106 participants
- Where
- No sites listed yet
- Study dates
- Apr 2014to Dec 2015
- How long will I take part?
- 1 Year
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: All consecutive adult patients undergoing total thyroidectomy during a 12-month period. All patients understood the various aspects of the study and gave written informed consent.
Who may be able to join
- To be at least 18 years old, to accept participation in the study, and to be scheduled for a total bilateral thyroidectomy.
Who cannot join
- Urgent thyroidectomy, inability to perform videostroboscopy, minor patients, patient refuse to be part of the study
About this study
Official title: Recurrent Laryngeal Nerve Monitoring for the Assessment of the Vocal Cords in Thyroid Surgery
In patients undergoing total thyroidectomy, intraoperative nerve monitoring according to the International Standards Guideline Statement may detect nerves more susceptible to injury. The aim of our study was to evaluate the independent risk factors of vocal cord palsy, including those related to pre-dissection nerve monitoring values.
Methods: Prospective observational study in 95 consecutive adult patients undergoing elective total thyroidectomy in Spain. A single experienced phonologist performed a videostroboscopy (VS) exam preoperatively and one week after surgery to assess vocal cord mobility. Each surgical procedure was performed with intermittent intraoperative neuromonitoring. Latency and amplitude values were obtained for the vagal and recurrent laryngeal nerves before surgical dissection and compared with the postoperative VS exam.
Read the detailed description
After ethics committee approval (PR AG 129/2014), a prospective observational study was carried out at Vall d'Hebron University Hospital, a tertiary hospital in Barcelona, Spain, in accordance with the Standards for Reporting of Diagnostic Accuracy (STARD), including all consecutive adult patients undergoing total thyroidectomy during a 12-month period. All patients understood the various aspects of the study and gave written informed consent. Patient characteristics recorded were age, sex, body mass index, ASA grade, and reason for surgery, among others.
Intraoperative neuromonitoring: Neural monitoring was performed once the carotid neurovascular bundle had been identified and throughout the surgical dissection process to ensure functional integrity of the nerve. We used Avalanche XT® (Dr Langer Medical GmbH, Waldkirch, Germany) equipment fitted with paired electrodes on the tracheal tube, in contact with the vocal cords (7-10 mm above the upper edge of the tube). Intermittent neuromonitoring was performed in each patient according to the international standard guidelines for electrophysiological monitoring20. The VN and RLN were stimulated following the four-step technique (V1: initial vagal stimulation, prior identification and dissection of the VN, R1: initial stimulation of the RLN, R2: post-dissection RLN stimulation, V2: post-dissection vagal stimulation). Vagal stimulation confirmed proper functioning of the entire neuronal circuit, while also avoiding false negatives through stimulation of an injured distal RLN at the lesion site. All signals were recorded on a monitor and collected for evaluation. Vagal and RLN stimulation was programmed at 3 mA and 1 mA, respectively. The event threshold was set to 70-100 uV, and increased to 200 uV, to avoid false-positive events appearing on the monitor due to spontaneous low-level respiratory waves < 100 uV. Electromyographic signals (latency and amplitude) as well as biphasic and triphasic waves were displayed on the monitoring screen. Lack of signal occurred when the monitor showed low-amplitude waves, disturbance of the isoelectric line, multiple waves of variable and scant amplitude, interference or substantial reduction in electromyography response (< 100 uV), and a high-pitched warning sound.
Vocal cords were assessed using VS (Laryngeal Strobe 9400, Pentax Medical, USA) by a single experienced phonologist blinded to the IONM results. The VS exam was performed preoperatively and repeated one week after surgery. The diagnosis of palsy (absence of motion) was made on the basis of an observation of asymmetrical laryngeal motion. Patients with postoperative VCP began voice therapy and were monitored periodically to assess their progress.
Statistics:
The main aim of the present study was to identify independent risk factors for VCP, including those related with pre-dissection IONM values. Continuous variables are expressed as the mean (standard deviation) or the median and interquartile range (i.q.r.) prior to verification of normality by the Kolmogorov-Smirnov test, and categorical variables are expressed as the absolute value (percentage).
The IONM results (response amplitude in uV and latency in ms) were compared with VS findings and classified as true positives (TP) when IONM values were abnormal and VCP was confirmed by VS, as true negatives (TN) when IONM values were normal and vocal cord mobility was normal on VS, as false positives (FP) when IONM values were obviously abnormal but vocal cord mobility was normal on VS, and as false negatives (FN) when IONM values were normal but VS revealed VCP. These IONM results were used to calculate sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), Youden incidence, with the respective 95% confidence interval (CI).
Perioperative variables included sex, age, BMI, ASA grade, neoplasm diagnosis, lymphadenectomy, and surgery. The bivariate relationship between each factor and the VCP results was analysed using an independent sample t test or the Mann-Whitney U-test, as appropriate, for continuous variables, and using the χ2 or Fisher exact test for dichotomous categorical variables. Receiver operating characteristic (ROC) curves were also plotted to determine the best cut-off points for pre-dissection latency and response amplitude for both VN and RLN to predict postoperative palsy.
These cut-off points were then included in the forward stepwise multivariate logistic regression to identify independent risk factors for VCP. Candidate variables for the logistic regression included sex, age, BMI, neoplasm diagnosis, lymphadenectomy, surgery duration, American Society of Anesthesiologists (ASA) classification, and IONM-related predictive factors such as pre-dissection VN latency, pre-dissection VN response amplitude, pre-dissection RLN latency, and pre-dissection RLN response amplitude.
The odds ratio (OR) and 95% CI were also calculated for all exposure factors. In all cases, the level of significance was set at less than 0.05. The statistical analysis was performed using the software package SPSS version 23.0 (IBM, Armonk, New York, USA).
- Conditions
- Recurrent Laryngeal Nerve Palsy, Risk Factors of Vocal Cord Palsy, Neuromonitoring in Thyroid Surgery
- Medical subject headings
- Vocal Cord Paralysis
What is being measured
The primary outcome is the main question the study is designed to answer.
Response amplitude in recurrent laryngeal nerve in uV
Response amplitude reflects summated EMG activity from individual muscle fibers of the thyroarytenoid. We define monitoring waveform response amplitude as the height from the vertical measurement from the apex of the positive waveform deflection to the lowest point in the opposite polarity phase of the waveform ( peak to peak). Lack of signal occurred when the monitor showed low-amplitude response waves, in electromyography response (< 100 uV), and a high-pitched warning sound.
Measured: Adult patients undergoing total thyroidectomy during a 12-month period
Response amplitude in vagal nerve in uV
Response amplitude reflects summated EMG activity from individual muscle fibers of the thyroarytenoid. We define monitoring waveform response amplitude as the height from the vertical measurement from the apex of the positive waveform deflection to the lowest point in the opposite polarity phase of the waveform ( peak to peak). Lack of signal occurred when the monitor showed low-amplitude response waves, in electromyography response (< 100 uV), and a high-pitched warning sound.
Measured: Adult patients undergoing total thyroidectomy during a 12-month period
Vocal cord palsy
Vocal cords were assessed using videostroboscopy(Laryngeal Strobe 9400, Pentax Medical, USA) by a single experienced phonologist blinded to the neuromonitoring results
Measured: The VS exam was performed one week after surgery, through study completion, an average of 1 yearThe diagnosis of palsy (absence of motion) was made on the basis of an observation of asymmetrical laryngeal motion.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Aug 2021
- Study startApr 2014
- Primary completionMay 2015
- Study completionDec 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Recurrent Laryngeal Nerve PalsyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 106 participants (actual)
- Target duration
- 1 Year
Sponsor and investigators
- Lead sponsor
- Hospital Universitari Vall d'Hebron Research Institute
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Enric Caubet, Study director, Hospital Vall d'Hebron , Barcelona. SpainMarcos De Miguel, Study chair, Hospital Vall d'Hebron , Barcelona. SpainOscar González, Study director, Hospital Vall d'Hebron , Barcelona. SpainMercedes Velasco, Ph, Study chair, Hospital Universitari Vall d'Hebron Research InstituteMiriam De Nadal, Study chair, Hospital Vall d'Hebron , Barcelona. SpainEva Pelaez, Principal investigator, Hospital Vall d'Hebron , Barcelona. Spain
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04986592
- Sponsor's protocol ID
- PR AG 129/2014
- Status last verified
- Aug 2021
- First submitted
- 16 Jun 2021
- Last updated
- 5 Aug 2021
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Aug 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Recurrent Laryngeal Nerve Monitoring for the Assessment of the Vocal Cords in Thyroid Surgery
- ClinicalTrials.gov ID
- NCT04986592
- Acronym / sponsor ID
- PR AG 129/2014
- Conditions
- Recurrent Laryngeal Nerve Palsy, Risk Factors of Vocal Cord Palsy, Neuromonitoring in Thyroid Surgery
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 106 participants (actual)
- Lead sponsor
- Hospital Universitari Vall d'Hebron Research InstituteUniversity, hospital or other
- Study start
- Apr 2014 (actual)
- Primary completion
- May 2015 (actual)
- Study completion
- Dec 2015 (actual)
- First posted
- 3 Aug 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In patients undergoing total thyroidectomy, intraoperative nerve monitoring according to the International Standards Guideline Statement may detect nerves more susceptible to injury. The aim of our study was to evaluate the independent risk factors of vocal cord palsy, including those related to pre-dissection nerve monitoring values.
Methods: Prospective observational study in 95 consecutive adult patients undergoing elective total thyroidectomy in Spain. A single experienced phonologist performed a videostroboscopy (VS) exam preoperatively and one week after surgery to assess vocal cord mobility. Each surgical procedure was performed with intermittent intraoperative neuromonitoring. Latency and amplitude values were obtained for the vagal and recurrent laryngeal nerves before surgical dissection and compared with the postoperative VS exam.
Detailed description
After ethics committee approval (PR AG 129/2014), a prospective observational study was carried out at Vall d'Hebron University Hospital, a tertiary hospital in Barcelona, Spain, in accordance with the Standards for Reporting of Diagnostic Accuracy (STARD), including all consecutive adult patients undergoing total thyroidectomy during a 12-month period. All patients understood the various aspects of the study and gave written informed consent. Patient characteristics recorded were age, sex, body mass index, ASA grade, and reason for surgery, among others.
Intraoperative neuromonitoring: Neural monitoring was performed once the carotid neurovascular bundle had been identified and throughout the surgical dissection process to ensure functional integrity of the nerve. We used Avalanche XT® (Dr Langer Medical GmbH, Waldkirch, Germany) equipment fitted with paired electrodes on the tracheal tube, in contact with the vocal cords (7-10 mm above the upper edge of the tube). Intermittent neuromonitoring was performed in each patient according to the international standard guidelines for electrophysiological monitoring20. The VN and RLN were stimulated following the four-step technique (V1: initial vagal stimulation, prior identification and dissection of the VN, R1: initial stimulation of the RLN, R2: post-dissection RLN stimulation, V2: post-dissection vagal stimulation). Vagal stimulation confirmed proper functioning of the entire neuronal circuit, while also avoiding false negatives through stimulation of an injured distal RLN at the lesion site. All signals were recorded on a monitor and collected for evaluation. Vagal and RLN stimulation was programmed at 3 mA and 1 mA, respectively. The event threshold was set to 70-100 uV, and increased to 200 uV, to avoid false-positive events appearing on the monitor due to spontaneous low-level respiratory waves < 100 uV. Electromyographic signals (latency and amplitude) as well as biphasic and triphasic waves were displayed on the monitoring screen. Lack of signal occurred when the monitor showed low-amplitude waves, disturbance of the isoelectric line, multiple waves of variable and scant amplitude, interference or substantial reduction in electromyography response (< 100 uV), and a high-pitched warning sound.
Vocal cords were assessed using VS (Laryngeal Strobe 9400, Pentax Medical, USA) by a single experienced phonologist blinded to the IONM results. The VS exam was performed preoperatively and repeated one week after surgery. The diagnosis of palsy (absence of motion) was made on the basis of an observation of asymmetrical laryngeal motion. Patients with postoperative VCP began voice therapy and were monitored periodically to assess their progress.
Statistics:
The main aim of the present study was to identify independent risk factors for VCP, including those related with pre-dissection IONM values. Continuous variables are expressed as the mean (standard deviation) or the median and interquartile range (i.q.r.) prior to verification of normality by the Kolmogorov-Smirnov test, and categorical variables are expressed as the absolute value (percentage).
The IONM results (response amplitude in uV and latency in ms) were compared with VS findings and classified as true positives (TP) when IONM values were abnormal and VCP was confirmed by VS, as true negatives (TN) when IONM values were normal and vocal cord mobility was normal on VS, as false positives (FP) when IONM values were obviously abnormal but vocal cord mobility was normal on VS, and as false negatives (FN) when IONM values were normal but VS revealed VCP. These IONM results were used to calculate sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), Youden incidence, with the respective 95% confidence interval (CI).
Perioperative variables included sex, age, BMI, ASA grade, neoplasm diagnosis, lymphadenectomy, and surgery. The bivariate relationship between each factor and the VCP results was analysed using an independent sample t test or the Mann-Whitney U-test, as appropriate, for continuous variables, and using the χ2 or Fisher exact test for dichotomous categorical variables. Receiver operating characteristic (ROC) curves were also plotted to determine the best cut-off points for pre-dissection latency and response amplitude for both VN and RLN to predict postoperative palsy.
These cut-off points were then included in the forward stepwise multivariate logistic regression to identify independent risk factors for VCP. Candidate variables for the logistic regression included sex, age, BMI, neoplasm diagnosis, lymphadenectomy, surgery duration, American Society of Anesthesiologists (ASA) classification, and IONM-related predictive factors such as pre-dissection VN latency, pre-dissection VN response amplitude, pre-dissection RLN latency, and pre-dissection RLN response amplitude.
The odds ratio (OR) and 95% CI were also calculated for all exposure factors. In all cases, the level of significance was set at less than 0.05. The statistical analysis was performed using the software package SPSS version 23.0 (IBM, Armonk, New York, USA).
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Target follow-up
- 1 Year
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- All consecutive adult patients undergoing total thyroidectomy during a 12-month period. All patients understood the various aspects of the study and gave written informed consent.
Key inclusion criteria (1 listed)
- To be at least 18 years old, to accept participation in the study, and to be scheduled for a total bilateral thyroidectomy.
Key exclusion criteria (1 listed)
- Urgent thyroidectomy, inability to perform videostroboscopy, minor patients, patient refuse to be part of the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Response amplitude in recurrent laryngeal nerve in uV
Time frame: Adult patients undergoing total thyroidectomy during a 12-month period
Response amplitude reflects summated EMG activity from individual muscle fibers of the thyroarytenoid. We define monitoring waveform response amplitude as the height from the vertical measurement from the apex of the positive waveform deflection to the lowest point in the opposite polarity phase of the waveform ( peak to peak). Lack of signal occurred when the monitor showed low-amplitude response waves, in electromyography response (< 100 uV), and a high-pitched warning sound.
Response amplitude in vagal nerve in uV
Time frame: Adult patients undergoing total thyroidectomy during a 12-month period
Response amplitude reflects summated EMG activity from individual muscle fibers of the thyroarytenoid. We define monitoring waveform response amplitude as the height from the vertical measurement from the apex of the positive waveform deflection to the lowest point in the opposite polarity phase of the waveform ( peak to peak). Lack of signal occurred when the monitor showed low-amplitude response waves, in electromyography response (< 100 uV), and a high-pitched warning sound.
Vocal cord palsy
Time frame: The VS exam was performed one week after surgery, through study completion, an average of 1 yearThe diagnosis of palsy (absence of motion) was made on the basis of an observation of asymmetrical laryngeal motion.
Vocal cords were assessed using videostroboscopy(Laryngeal Strobe 9400, Pentax Medical, USA) by a single experienced phonologist blinded to the neuromonitoring results
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Aug 2021.
Related trials for Recurrent Laryngeal Nerve Palsy
Not yet recruiting
Endotracheal Tube Versus Transcartilage Needle Electrodes for Nerve Monitoring in Thyroid Surgery
Thyroid Diseases, Recurrent Laryngeal Nerve Injury
Not yet recruiting
Recurrent Laryngeal Nerve Monitoring During Pediatric Aerodigestive Tract and Cardiac Surgery
Unilateral Vocal Cord Paralysis, Unilateral Vocal Cord Paresis
Not yet recruitingPhase 1
Single Dose 4-Aminopyridine for Diagnosing Recurrent Laryngeal Nerve Paralysis Continuity After Trauma
Vocal Cord Paralysis, Recurrent Laryngeal Nerve Palsy
RecruitingObservational study
Detection of Vocal Fold Motion Impairment on Noninvasive Positive Pressure
Vocal Cord Dysfunction, Vocal Cord Paralysis
Active, not recruitingObservational study
CT and Endoscopic Biopsy Image-Based Deep Learning for Predicting Left Recurrent Laryngeal Nerve Lymph Node Metastasis in Esophageal Cancer
Esophageal Squamous Cell Cancer (SCC), Recurrent Laryngeal Nerve Palsy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Enric Caubet study director
Hospital Vall d'Hebron , Barcelona. Spain
Marcos De Miguel study chair
Hospital Vall d'Hebron , Barcelona. Spain
Oscar González study director
Hospital Vall d'Hebron , Barcelona. Spain
Questions about this trial
What is this clinical trial studying?
An observational study of Recurrent Laryngeal Nerve Palsy and Risk Factors of Vocal Cord Palsy, run by Hospital Universitari Vall d'Hebron Research Institute.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Response amplitude in recurrent laryngeal nerve in uV (time frame: Adult patients undergoing total thyroidectomy during a 12-month period). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2021.